Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Qualcomms reported performance-focused global layoffs are drawing attention, with traders divided between viewing the cuts as a sign of underperformance and as potential cost discipline; the number of jobs affected has not been specified. Discussion also centers on the stocks relative strength against weaker chip peers and its setup ahead of earnings.

SHIB is drawing attention around a prolonged consolidation and traders debate over whether it can break higher with a broader meme-coin or altcoin rally. Bullish holders are accumulating and anticipating a rebound, while skeptics cite its stagnant performance, limited utility, and lack of meaningful token burns.

Valero is drawing attention for record results powered by unusually strong refining margins, as fuel-supply disruptions and tight diesel markets support crack spreads. Traders are split between viewing the fundamentals as a tailwind and warning that the sharp rally may be vulnerable to profit-taking, shifting oil flows, and policy headlines.

Instacarts reported sale exploration and preliminary talks with Uber and DoorDash are driving discussion, with traders debating whether an acquisition would expand Ubers grocery-delivery reach or add cost and antitrust risk. Some point to reports that Uber walked away and view that as avoiding a costly deal, though the talks remain preliminary.

Disney is drawing attention for a gradual technical rebound, with traders citing bullish momentum and watching whether shares can break through recent resistance ahead of the next earnings report. Others say repeated rejection at resistance and the stocks long-running lack of appreciation could stall the move.

Lillys first Phase 1 results for its ovarian-cancer ADC combinationshowing a 79% confirmed response rate and 100% disease controlare drawing attention as a pipeline update beyond its obesity franchise. The broader discussion remains focused on GLP-1 growth and mixed reactions to the stocks price moves.

Attention centers on Candels CAN-2409 prostate cancer program, especially its planned BLA submission in the fourth quarter of 2026, with clinical updates and upcoming NSCLC and glioblastoma presentations adding speculative interest. Bullish traders point to the data and regulatory progress, while others focus on the sharp pullback, possible dilution, and concern about the filing timeline and CEO share sales.

Hut 8 is drawing attention amid a steep selloff across bitcoin-miner and AI data-center stocks, with traders citing bitcoin weakness, higher financing costs, and concerns about AI infrastructure demand and project execution. Bulls remain focused on the companys data-center pivot and pipeline, while bears question its capital needs and ability to deliver; earnings are a key focal point.

Reported takeover interest from Lundbeck has fueled speculation about a potential acquisition, with traders debating possible offers despite Xeris saying it is not for sale and no deal being confirmed. The discussion is also supported by optimism about Recorlevs growth and XP-8121s long-term potential, while some traders caution that the pipeline remains years from commercialization.

Target is drawing attention after giving back a recent rally, with traders debating whether the pullback is profit-taking or a sign of further weakness; bullish options traders see a possible recovery into the next earnings report. The broader turnaround case rests on a strong quarterly report and raised outlook, though some traders caution that one-time tariff refunds boosted results.